The concept of Diabetes & CV risk: A lifetime risk challenge John Deanfield, MD University College London London, United Kingdom Cardio Diabetes Master.
Neoadjuvant/Adjuvant Treatment of RCC Giuseppe Procopio Fondazione IRCCS Istituto Nazionale Tumori Milano HIGHLIGTHS IN ADVANCED RENAL CELL CARCINOMA MANAGEMENT.
Recent advances in the management of viral hepatitis handout
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia.
Which Patients for Subcutaneous Immunotherapy? Harold S. Nelson. MD Professor of Medicine National Jewish Heath University of Colorado Denver School of.
Which Patients for Subcutaneous Immunotherapy?
